Evidence map›Paper›PMID 39611931›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2024

Comparative Analysis of Dose Gradients and Valley Doses in Pelvic Lattice Radiotherapy in RapidArc and IMRT.

Bhagyalakshmi At, Velayudham Ramasubramanian

Abstract readComparative Study
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bhagyalakshmi AtSchool of Advanced Sciences, Vellore Institute of Technology, Vellore, India.ORCID 0000-0001-6675-9069
Velayudham RamasubramanianSchool of Advanced Sciences, Vellore Institute of Technology, Vellore, India.ORCID 0000-0002-4834-1141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study evaluated the dose fall off and valley dose percentage in pelvic cancer Lattice Radiotherapy (LRT) using various treatment techniques.

methodsForty five treatment plans were developed for 15 patients undergoing radiotherapy using a linear accelerator. Plans were categorized into three sets: RapidArc (RA), seven-field intensity-modulated radiation therapy (IMRT), and nine-field IMRT, both for high-dose (HD) vertices and the entire planning target volume (PTV). Dose fall-off indices were analyzed using the normalized dose fall-off index (ʌ) to compare the rate of dose decrease beyond HD vertices. Valley dose percentages were determined by analyzing dose profiles between HD vertices to quantify lower dose percentages. Analysis involved averaging normalized dose fall-off index (ʌ) values, valley dose percentages and grouping valley doses to assess variation with respect to center-to-center (CTC) intervals between HD vertices for all the techniques.

resultsRA plans achieved sharper dose fall-off beyond HD vertices compared to seven-field and nine-field IMRT techniques, with decreasing values as distance from the central plane increased. RA plans also exhibited higher valley doses (62.05%) relative to nine-field IMRT (55.02%) and seven-field IMRT (56.56%) for an average CTC distance of 3.75 cm, showing significant variability across CTC intervals.

conclusionsRA plans achieve steeper dose fall-off and higher valley doses compared to IMRT, effective for pelvic LRT but less suitable for grid therapy due to challenges with MLCs. Minimal differences in valley doses between nine-field and seven-field IMRT suggest limited impact from beam angles, guiding treatment optimization. The equations derived can be utilized for dosimetric evaluation and clinical planning in grid therapy, emphasizing their practical relevance in treatment strategy development.

Indexed as

Radiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedFemaleFollow-Up StudiesHumansMaleOrgans at RiskParticle AcceleratorsPelvic NeoplasmsPelvisPrognosisDose fall off indexhigh dose verticeslattice therapypeak dosevalley dose

Identifiers

PMID39611931
PMCPMC11996128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.